Sinopharm Group

Waardering

K/W (TTM)

6,44

K/W (verwacht)

5,49

Winst per aandeel

HK$ 2,65

Koers/boekwaarde

0,54

Bèta

0,48

Kerncijfers

Omzet (TTM)

HK$ 574,27 mld

EBITDA

HK$ 19,14 mld

Winstmarge

1,24%

Rendement eigen verm. (ROE)

8,10%

Omzetgroei

-0,60%

Uitstaande aandelen

1.341.810.740

Dividend

Dividendrendement

4,62%

Dividend p/a

HK$ 0,79

Uitkeringsratio

29,49%

Over Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. Sinopharm Group Co. Ltd. was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.